Journal article · 2022
N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review
Letters in Organic Chemistry, 20(4), 287–299 · Published 28 October 2022 · DOI 10.2174/1570178620666221026095145
In brief
“N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review” is a 2022 journal article by Faryal Chaudhry and 2 co-authors, published in Letters in Organic Chemistry. OpenAlex counts 11 citations as of 15 November 2026, which puts it in the top 7% of works published in 2022 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 11
- Most cited in
- 2026 (6)
- Field-weighted impact
- 0.42
- References
- 77
- Authors
- 3
Abstract
Presence of N-heterocyclic ring systems as promising features in the molecular skeleton of FDA approved drugs, underlie the remarkable contributions of these heterocyclic nuclei in the field of medicine. Despite instability risks associated with COVID pandemic, the US FDA approved 50 drugs (36 NMEs and 14 biological products) in the year 2021. The active ingredients… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Chaudhry, F., Munir, R., & Malik, N. (2022). N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review. Letters in Organic Chemistry, 20(4), 287–299. https://doi.org/10.2174/1570178620666221026095145
MLA 9
Chaudhry, Faryal, et al. “N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review.” Letters in Organic Chemistry, vol. 20, no. 4, 2022, pp. 287–299. https://doi.org/10.2174/1570178620666221026095145.
Chicago
Chaudhry, Faryal, Rubina Munir, and Nayab Malik. 2022. “N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review.” Letters in Organic Chemistry 20 (4): 287–299. https://doi.org/10.2174/1570178620666221026095145.
Harvard
Chaudhry, F., Munir, R. and Malik, N. (2022) ‘N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review’, Letters in Organic Chemistry, 20(4), pp. 287–299. doi:10.2174/1570178620666221026095145.
IEEE
F. Chaudhry, R. Munir, and N. Malik, “N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review,” Letters in Organic Chemistry, vol. 20, no. 4, pp. 287–299, 2022, doi: 10.2174/1570178620666221026095145.
BibTeX
@article{chaudhry2022heterocycles,
title = {{N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review}},
author = {Chaudhry, Faryal and Munir, Rubina and Malik, Nayab},
journal = {Letters in Organic Chemistry},
year = {2022},
volume = {20},
number = {4},
pages = {287--299},
doi = {10.2174/1570178620666221026095145},
url = {https://doi.org/10.2174/1570178620666221026095145}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 2 | |
| 2024 | 3 | |
| 2026 | 6 |
Its field-weighted citation impact is 0.42: it has been cited 0.42 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- nitrogen heterocycles
- privileged scaffolds
- new chemical entities
- FDA-approved drugs
- small molecule drugs
- drug-likeness
- pharmacokinetics
- heterocyclic ring systems
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Chaudhry, F., Munir, R., & Malik, N. (2022). N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review. Letters in Organic Chemistry, 20(4), 287–299. https://doi.org/10.2174/1570178620666221026095145
How many times has this paper been cited?
11 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Faryal Chaudhry, Rubina Munir, Nayab Malik.
What is the DOI of this paper?
10.2174/1570178620666221026095145. The permanent link is https://doi.org/10.2174/1570178620666221026095145.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.